Anchor investor and private banking group supporting Lightrock funds.
Portfolio
2
companies
CMR Surgical
CMR Surgical manufactures the Versius system for robotic minimal access surgery.
Lightrock
Lightrock operates a global private equity platform that backs purpose-driven entrepreneurs.
Umur Hursever
Partner
The upsized funding round was led by existing backers including Ally Bridge Group and Lightrock.
"Versius is very well suited to our needs as a world-leading thoracic surgery department. We have successfully helped patients get the benefit of robotic assisted surgery and we look forward to developing our robotics programme working with CMR and other centres around the world as the adoption of Versius continues."
The inaugural fund closed above its initial target with backing from a diverse group of institutional investors and foundations.
"I want to extend my grateful thanks to our investors for their confidence in and support of our mission. This is Lightrock’s third successful fund close in little over a year and it represents a resounding endorsement of our mission to scale impact investing."
The record European medtech financing was backed by new US investors and existing partners including LGT and Cambridge Innovation Capital.
"We are pleased to welcome new US investors whose calibre and scale are reflective of the scale of CMR's mission to transform surgery. I would also like to thank our existing investors for their long-term commitment in supporting this company to achieve its global mission. The significant capital injection in a UK scale-up reconfirms my belief that the Cambridge eco system has fostered a unique pool of diverse talents and competencies that will help drive our innovation in the years ahead. With new and existing investors onboard, CMR is well-placed to make surgical robotics accessible for all."
